Torrent Pharmaceuticals Statistics
Total Valuation
NSE:TORNTPHARM has a market cap or net worth of INR 1.06 trillion. The enterprise value is 1.08 trillion.
Market Cap | 1.06T |
Enterprise Value | 1.08T |
Important Dates
The last earnings date was Friday, May 23, 2025.
Earnings Date | May 23, 2025 |
Ex-Dividend Date | Jun 20, 2025 |
Share Statistics
Current Share Class | 338.45M |
Shares Outstanding | n/a |
Shares Change (YoY) | -0.01% |
Shares Change (QoQ) | +0.15% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 105.92M |
Valuation Ratios
The trailing PE ratio is 55.45 and the forward PE ratio is 42.44.
PE Ratio | 55.45 |
Forward PE | 42.44 |
PS Ratio | 9.20 |
PB Ratio | 13.96 |
P/TBV Ratio | 35.45 |
P/FCF Ratio | 53.68 |
P/OCF Ratio | 40.99 |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 29.15, with an EV/FCF ratio of 54.95.
EV / Earnings | 56.76 |
EV / Sales | 9.42 |
EV / EBITDA | 29.15 |
EV / EBIT | 37.07 |
EV / FCF | 54.95 |
Financial Position
The company has a current ratio of 1.19, with a Debt / Equity ratio of 0.42.
Current Ratio | 1.19 |
Quick Ratio | 0.54 |
Debt / Equity | 0.42 |
Debt / EBITDA | 0.86 |
Debt / FCF | 1.62 |
Interest Coverage | 11.61 |
Financial Efficiency
Return on equity (ROE) is 26.46% and return on invested capital (ROIC) is 16.86%.
Return on Equity (ROE) | 26.46% |
Return on Assets (ROA) | 12.17% |
Return on Invested Capital (ROIC) | 16.86% |
Return on Capital Employed (ROCE) | 28.48% |
Revenue Per Employee | 7.33M |
Profits Per Employee | 1.22M |
Employee Count | 15,718 |
Asset Turnover | 0.77 |
Inventory Turnover | 1.15 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +16.24% in the last 52 weeks. The beta is 0.17, so NSE:TORNTPHARM's price volatility has been lower than the market average.
Beta (5Y) | 0.17 |
52-Week Price Change | +16.24% |
50-Day Moving Average | 3,232.13 |
200-Day Moving Average | 3,273.66 |
Relative Strength Index (RSI) | 39.95 |
Average Volume (20 Days) | 350,288 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NSE:TORNTPHARM had revenue of INR 115.16 billion and earned 19.11 billion in profits. Earnings per share was 56.47.
Revenue | 115.16B |
Gross Profit | 87.40B |
Operating Income | 29.26B |
Pretax Income | 26.73B |
Net Income | 19.11B |
EBITDA | 37.21B |
EBIT | 29.26B |
Earnings Per Share (EPS) | 56.47 |
Balance Sheet
The company has 6.91 billion in cash and 32.02 billion in debt, giving a net cash position of -25.11 billion.
Cash & Cash Equivalents | 6.91B |
Total Debt | 32.02B |
Net Cash | -25.11B |
Net Cash Per Share | n/a |
Equity (Book Value) | 75.91B |
Book Value Per Share | 224.22 |
Working Capital | 9.06B |
Cash Flow
In the last 12 months, operating cash flow was 25.85 billion and capital expenditures -6.11 billion, giving a free cash flow of 19.74 billion.
Operating Cash Flow | 25.85B |
Capital Expenditures | -6.11B |
Free Cash Flow | 19.74B |
FCF Per Share | n/a |
Margins
Gross margin is 75.89%, with operating and profit margins of 25.41% and 16.59%.
Gross Margin | 75.89% |
Operating Margin | 25.41% |
Pretax Margin | 23.21% |
Profit Margin | 16.59% |
EBITDA Margin | 32.31% |
EBIT Margin | 25.41% |
FCF Margin | 17.14% |
Dividends & Yields
This stock pays an annual dividend of 32.00, which amounts to a dividend yield of 1.02%.
Dividend Per Share | 32.00 |
Dividend Yield | 1.02% |
Dividend Growth (YoY) | 14.29% |
Years of Dividend Growth | 1 |
Payout Ratio | 56.67% |
Buyback Yield | 0.01% |
Shareholder Yield | 1.02% |
Earnings Yield | 1.80% |
FCF Yield | 1.86% |
Stock Splits
The last stock split was on July 8, 2022. It was a forward split with a ratio of 2.
Last Split Date | Jul 8, 2022 |
Split Type | Forward |
Split Ratio | 2 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | n/a |